Nutraceutical International Corporation reported unaudited consolidated earnings results for the fourth quarter and year ended September 30, 2014. For the quarter, the company reported net sales of $52,440,000 against $51,256,000 a year ago. Income from operations was $5,688,000 against $6,988,000 a year ago. Income before provision for income taxes was $5,291,000 against $6,652,000 a year ago. Net income was $3,433,000 or $0.35 per basic and diluted share against $4,136,000 or $0.42 per basic and diluted share a year ago. Adjusted EBITDA was $9,066,000 against $9,578,000 a year ago.

For the year, the company reported net sales of $214,474,000 against $208,397,000 a year ago. Income from operations was $26,497,000 against $28,133,000 a year ago. Income before provision for income taxes was $25,076,000 against $26,773,000 a year ago. Net income was $15,889,000 or $1.62 per diluted share against $17,008,000 or $1.73 per diluted share a year ago. Adjusted EBITDA was $38,232,000 against $38,048,000 a year ago. Operating cash flow for the fiscal year ended September 30, 2014 was $20.0 million compared to $26.8 million for fiscal 2013. The operating cash flow for the fiscal year ended September 30, 2014, combined with net borrowings of $10.5 million and existing cash, was primarily used to invest $16.4 million in acquisitions of natural product businesses, $11.3 million in purchases of property, plant and equipment and $5.1 million in purchases of common stock for treasury. Net sales growth of 2.9% was comparable to fiscal 2013 net sales growth of 4.0%. Fiscal 2014 growth came primarily from acquisitions completed during the last two fiscal years. Adjusted EBITDA for fiscal 2014 increased slightly despite the increased costs and internal time dedicated to recent acquisitions. The decrease in fiscal 2014 net income was primarily a result of increased amortization and depreciation expense relating to acquisitions and capital investments made to enhance future growth and reduce costs, including a substantial investment in new laboratory facilities and equipment.